Harnessing phytoconstituents in ethosomes: A new frontier in skin disorder management
- PMID: 39870257
- DOI: 10.1016/j.ijpharm.2025.125273
Harnessing phytoconstituents in ethosomes: A new frontier in skin disorder management
Abstract
The rising incidence of skin disorders has necessitated the exploration of innovative therapeutic modalities that harness the beneficial properties of natural compounds. Phytoconstituents, renowned for their diverse pharmacological attributes, present considerable promise in the management of various dermatological conditions. This review delineates the integration of phytoconstituents into ethosomal formulations, which are advanced lipid-based carriers specifically designed to enhance transdermal delivery. We discuss the advantages conferred by ethosomes, including their capacity to improve the stability and bioavailability of phytochemicals, facilitate deeper skin penetration, and provide controlled release profiles. Recent advancements in the formulation of ethosomes encapsulating a variety of phytoconstituents are highlighted, with a focus on their physicochemical properties, therapeutic efficacy, and safety profiles. Furthermore, the review examines the mechanisms by which ethosomes enhance the delivery of bioactive compounds to targeted skin layers, particularly in the context of treating conditions such as acne, eczema, and psoriasis. Challenges associated with formulation stability and scalability are also addressed, along with potential future research directions in this domain. By synthesizing current knowledge and identifying existing gaps, this article aims to provide a comprehensive overview of phytoconstituent-based ethosomes as a promising strategy for the development of effective and safe topical therapies for skin disorders. Ultimately, this review underscores the potential of these innovative formulations to improve patient outcomes and contribute significantly to the advancement of dermatological treatment options.
Keywords: Dermatological; Natural compounds; Phytoconstituents; Skin disorders; Transdermal delivery.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Ethosomes: a potential nanovesicular carrier to enhancing the drug delivery against skin barriers.J Microencapsul. 2024 May;41(3):204-225. doi: 10.1080/02652048.2024.2326085. Epub 2024 Mar 8. J Microencapsul. 2024. PMID: 38456667 Review.
-
Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.Pharm Res. 2021 Jun;38(6):947-970. doi: 10.1007/s11095-021-03053-5. Epub 2021 May 25. Pharm Res. 2021. PMID: 34036520 Review.
-
Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis.J Nanobiotechnology. 2024 Sep 28;22(1):584. doi: 10.1186/s12951-024-02860-3. J Nanobiotechnology. 2024. PMID: 39334378 Free PMC article.
-
Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.J Control Release. 2007 Nov 6;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. Epub 2007 Aug 16. J Control Release. 2007. PMID: 17884226
-
A complete sojourn on nanotechnological advancements and nanocarrier applications in psoriasis management.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):6453-6471. doi: 10.1007/s00210-025-03804-w. Epub 2025 Jan 23. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39847054 Review.
Cited by
-
Applications of Traditional Herbal Ingredients in Skincare: Mapping the Research Landscape and Innovation Trajectories Over Four Decades.J Cosmet Dermatol. 2025 Jul;24(7):e70363. doi: 10.1111/jocd.70363. J Cosmet Dermatol. 2025. PMID: 40686194 Free PMC article. Review.
-
Investigation of the in vivo and in silico wound healing property of Retama raetam (Forssk) Webb & Berthel. leaves extract.Front Pharmacol. 2025 Jul 31;16:1621579. doi: 10.3389/fphar.2025.1621579. eCollection 2025. Front Pharmacol. 2025. PMID: 40832601 Free PMC article.
-
A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems.Polymers (Basel). 2025 Jun 4;17(11):1566. doi: 10.3390/polym17111566. Polymers (Basel). 2025. PMID: 40508808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical